Evidence map›Paper›PMID 35461791›Full record

ArticleJournal of geriatric oncology2022

Remaining Agile in the COVID-19 pandemic healthcare landscape - How we adopted a hybrid telemedicine Geriatric Oncology care model in an academic tertiary cancer center.

Matthew Chen, Noorhanah Mohd Said, Nydia Camelia Mohd Rais, Francis Ho, Natalie Ling, Meiling Chun, Yean Shin Ng, Wan Nghee Eng, Yao Yao, Beatriz Korc-Grodzicki and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of geriatric oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Matthew ChenDivision of Geriatric Medicine, Department of Medicine, National University Hospital, Singapore.
Noorhanah Mohd SaidDepartment of Oncology Nursing, National University Cancer Institute, Singapore.
Nydia Camelia Mohd RaisDivision of Geriatric Medicine, Department of Medicine, Ng Teng Fong General Hospital, Singapore.
Francis HoDepartment of Radiation Oncology, National University Cancer Institute, Singapore.
Natalie LingDivision of Geriatric Medicine, Department of Medicine, National University Hospital, Singapore.
Meiling ChunDepartment of Surgery, Ng Teng Fong General Hospital, Singapore.
Yean Shin NgDepartment of Haematology Oncology, National University Cancer Institute, Singapore.
Wan Nghee EngDepartment of Oncology Nursing, National University Cancer Institute, Singapore.
Yao YaoDepartment of Pharmacy, National University Hospital, Singapore.
Beatriz Korc-GrodzickiDepartment of Geriatrics, Memorial Sloan Kettering Cancer Center, New York.
Angela PangDepartment of Haematology Oncology, National University Cancer Institute, Singapore. Electronic address: angelapang81@gmail.com.
National University Cancer Institute, Singapore · SGNational University Hospital · SGNg Teng Fong General Hospital · SGMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

introductionThe COVID-19 pandemic has impacted healthcare on an unprecedented scale, with healthcare resources being channeled into managing the devastating effects of the outbreak. Healthcare provision for vulnerable older adults has also been affected by lockdowns and suspension of selected medical services worldwide. In our tertiary cancer center, the National University Cancer Institute, Singapore (NCIS), our Geriatric Oncology (GO) service for older adults with cancer was halted for five months. In this paper, we describe the adoption of a hybrid telemedicine model by our GO service to continue care provision for older adults in the midst of the pandemic. MATERIALS AND

methodsComprehensive geriatric assessments (CGA) were done via telemedicine and virtual multidisciplinary discussions were held prior to the patients' clinic visits. A hybrid telemedicine consultation allowed geriatricians and oncologists, segregated in different sites during the pandemic, to provide a hybrid physical and video geriatric oncology consultation. Scheduled phone follow ups by GO nurses helped to monitor patients for treatment-related toxicities and geriatric syndromes.

resultsTwo hundred fifty patients were enrolled in the program from July 2020 to August 2021. All were assessed with a CGA, with 240 receiving interventions in the one-stop clinic. The average amount of time spent per visit was shortened from four hours to two and a half hours with an average of three interventions on the same day, versus one previously. Of the patients who received interventions, 84.8% were satisfied with the hybrid telemedicine model and 80.8% of them had reported a maintained or improved quality of life after being enrolled in the program. DISCUSSION: Telemedicine has been widely adopted during the pandemic, but older adults with limited digital literacy may find it a challenge. Our hybrid telemedicine model has allowed us to continue to provide cancer care, identify issues brought about by social isolation, and render timely assistance. It has become imperative to adapt, prepare and plan for the challenges we may face amid the ongoing COVID-19 pandemic and similar future outbreaks. Only by doing so can we remain agile and resilient, to continue providing quality care to our older patients with cancer.

Indexed as

COVID-19NeoplasmsTelemedicineAgedCommunicable Disease ControlDelivery of Health CareHumansPandemicsQuality of LifeSARS-CoV-2COVID19Geriatric oncologyPandemicTelehealthTelemedicine

Identifiers

PMID35461791
PMCPMC9005364
OpenAlexW4224080223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.